Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong

被引:37
|
作者
Cheng, SWK [1 ]
Ting, ACW [1 ]
Lau, H [1 ]
Wong, J [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China
关键词
D O I
10.1007/PL00013161
中图分类号
R61 [外科手术学];
学科分类号
摘要
The epidemiology of atherosclerotic peripheral arterial disease (PAD) has rarely been studied in Asia. A prospective vascular registry consisting of 510 Chinese patients with PAD from a teaching hospital in Hong Kong disclosed a male/female ratio of 1.6:1.0 with a mean age of 72 years. The predominant pattern was femoropopliteal occlusive disease (49%). Half of all patients had tissue loss on presentation, more so in women (67%) than men (38%). Demographic and biochemical risk factors examined showed many similarities with the West, included smoking (59%), hypertension (55%), diabetes mellitus (42%), hypercholesterolemia (55%), elevated low density lipoprotein (LDL) (60%), triglycerides (31%), hyperfibrinogenemia (62%), and hyperglycemia (49%). Chinese female patients with PAD were older and had a high prevalence of diabetes mellitus (54%). Smoking is less a problem in women (28%). They suffered predominantly from femoropopliteal and distal vessel disease, and two-thirds presented with tissue loss. Female patients also have significantly higher levels of fasting glucose, cholesterol, triglyceride, LDL, and very low density lipoprotein (VLDL). Male patients were mostly smokers (80%) with a higher proportion of aortoiliac disease. Critical ischemia in the form of tissue loss was associated with female sex (p < 0.001), age (p < 0.001), nonsmoking (p < 0.001), diabetes (p < 0.005), a low hemoglobin/hematocrit (p < 0.001), a high white blood cell count (p < 0.001), and high levels of fibrinogen (p < 0.001) and cholesterol (p < 0.05). An increasing incidence of PAD was noted in Hong Kong. Most of the patients present late with advanced ischemia, It is possible that this disease pattern represents only a fraction of the true incidence of PAD in the territory..
引用
收藏
页码:202 / 206
页数:5
相关论文
共 50 条
  • [41] Antithrombotic therapy in peripheral arterial occlusive disease
    Jackson, MR
    Clagett, GP
    CHEST, 2001, 119 (01) : 283S - 299S
  • [42] Ischaemic myopathy of peripheral arterial occlusive disease
    Vaquero Morillo, F.
    Ballesteros Pomar, M.
    Fernandez Moran, M. C.
    ANGIOLOGIA, 2010, 62 (01): : 20 - 25
  • [43] EXPERIENCE WITH BUFLOMEDIL IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    BALAS, P
    PAGRATIS, N
    ANGIOLOGY, 1981, 32 (10) : 679 - 685
  • [44] ARTERIAL HOMOGRAFTS FOR PERIPHERAL ARTERIOSCLEROTIC OCCLUSIVE DISEASE
    DEBAKEY, ME
    CRAWFORD, ES
    CREECH, O
    COOLEY, DA
    CIRCULATION, 1957, 15 (01) : 21 - 30
  • [45] PROSTANOIDS IN THERAPY OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    CREUTZIG, A
    CASPARY, L
    THERAPIE, 1991, 46 (03): : 241 - 245
  • [46] Antithrombotic therapy in peripheral arterial occlusive disease
    Jackson, MR
    Clagett, GP
    CHEST, 1998, 114 (05) : 666S - 682S
  • [47] Peripheral arterial Occlusive Disease: not old Hat!
    Ruemenapf, G.
    GEFASSCHIRURGIE, 2021, 26 (02): : 79 - 80
  • [48] Antithrombotic Treatment for Peripheral Arterial Occlusive Disease
    Hardung, David
    Behne, Andrea
    Boral, Mehmet
    Giesche, Carsten
    Langhoff, Ralf
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2021, 118 (31-32): : 528 - +
  • [49] Antithrombotic therapy in peripheral arterial occlusive disease
    Clagett, GP
    Sobel, M
    Jackson, MR
    Lip, GYH
    Tangelder, M
    Verhaeghe, R
    CHEST, 2004, 126 (03) : 609S - 626S
  • [50] Diabetes and risk for peripheral arterial occlusive disease
    Planas, A
    Clará, A
    Gasol, A
    Moner, A
    Contreras, C
    Hernández, R
    Concustell, R
    Ortiz, MA
    Pou, JM
    DIABETOLOGIA, 1998, 41 : A123 - A123